A single intravitreal injection of ocriplasmin may be considered medically necessary for treatment of an eye with symptomatic vitreomacular adhesion or vitreomacular traction.
The use of intravitreal ocriplasmin is considered investigational in all other situations, including use of repeat injections of ocriplasmin. .